University of Medicine and Dentistry of New Jersey
Closed portfolio with an early-phase archive tilt
According to ClinicalTrials.gov-derived indexes, University of Medicine and Dentistry of New Jersey sits in the top decile of US sponsors by registered trial count (#265 of 15,742 sponsors by registered trial count).
University of Medicine and Dentistry of New Jersey: 88 sponsored US clinical trials, none currently recruiting.
University of Medicine and Dentistry of New Jersey sponsors 88 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 56 completed. 14 of these trials are in Phase 3-4 (later-stage) and 36 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 2 trials.
Top-decile sponsor footprint
University of Medicine and Dentistry of New Jersey ranks in the top decile of sponsors by registered trial count (#265 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
56 of 88 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (63.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Indexed trials (enrollment closed)
88 total, page 1 of 2
Effect IV Ibuprofen and Inflammatory Responses
NCT01938040
Does Preop Midazolam Maintain Blood Glucose Norms in the Non Diabetic Perioperative Period
NCT01641653
Effect of Probiotics on Health-related Quality of Life in College Students With Upper Respiratory Infections
NCT01657643
Effect of Hamstring Stretching and Neural Mobilization on Range of Motion and Low Back Pain
NCT01483573
Partially HLA-Matched Irradiated Allogeneic Cellular Therapy After Reduced Intensity Total Body Irradiation
NCT00996359
Effect of Ambient Light on the Parameters of the Pupillary Light Reflex
NCT01207817
Exploring Massage Benefits for Arthritis of the Knee
NCT00970008
Remote Ischemic Preconditioning In Abdominal Organ Transplantation
NCT00975702
Vitamin E Supplements in Preventing Cancer in Patients at Risk of Prostate Cancer or Who Have Prostate Cancer
NCT00895115
The Effects of Different Ventilator Strategies on Inflammation and Injury in Normal Lungs
NCT01003730
Skin Sterility After Ethyl-Chloride Spray
NCT01292850
Ixabepilone and Hydroxychloroquine in Treating Patients With Metastatic Breast Cancer
NCT00765765
Oxygen Therapy for the Treatment of Undifferentiated Headache in the Emergency Department
NCT00856232
Docetaxel and Hydroxychloroquine in Treating Patients With Metastatic Prostate Cancer
NCT00786682
Radiation Therapy Using Gold Markers in Treating Women With Early-Stage Breast Cancer
NCT00749437
Hydroxychloroquine, Carboplatin, Paclitaxel, and Bevacizumab in Recurrent Advanced Non-Small Cell Lung Cancer
NCT00728845
Effects of Sevoflurane and Propofol on Light Flash Evoked Pupillometry
NCT00695890
Phase I Study of Patupilone and RAD001
NCT00496600
The Association Between Peri-Operative Hyperglycemia and Major Morbidity and Mortality
NCT00487162
Use of Xyrem to Improve Sleep in Chronic Fatigue Syndrome
NCT00498485
Decrease Emergence Agitation and Provide Pain Relief for Children Undergoing Tonsillectomy & Adenoidectomy
NCT00468052
A Computer-Based Intervention for Medically Unexplained Physical Symptoms
NCT00468013
Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors
NCT00667641
Riluzole in Treating Patients With Stage III or Stage IV Melanoma That Can Be Removed by Surgery
NCT00667901
Attention Shaping Procedures for Improving Psychosocial Skills Among Adults With Schizophrenia
NCT00391677
Pain and Sensory Changes Assessment in HIV+ Patients
NCT00422695
Omega 3 Fatty Acids in the Treatment of Children With Autism Spectrum Disorders
NCT00467818
Measuring Smoking Behavior in People With Schizophrenia and Bipolar Disorder
NCT00382915
Addressing Disparities in Cancer Care for Latino Medicare Beneficiaries
NCT00385866
Vagus Nerve Stimulation for Treating Adults With Severe Fibromyalgia
NCT00294281
Can Blood Glucose Levels During the Perioperative Period Identify a Population at Risk for Hyperglycemia?
NCT00468494
Intraocular Pressure During Prone Spinal Surgery
NCT00176722
Efficacy of Aripiprazole Versus Placebo in the Reduction of Aggressive and Aberrant Behavior in Autistic Children
NCT00468130
Treatment of Insomnia in Patients With Parkinson's Disease: A Multi-site, Placebo-controlled Study of Eszopiclone
NCT00324896
Motivational Interviewing to Improve Medication Adherence Among Hispanic Adults With Depression
NCT00356304
Oxcarbazepine Versus Placebo in Childhood Autism
NCT00467753
Gemcitabine With or Without Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Kidney Cancer
NCT00323791
First-Line Capecitabine and Cetuximab for Metastatic Colorectal Ca in Elderly Patients
NCT00251186
The Metabolic Effects of Almond Consumption in Adults With Pre-Diabetes
NCT00270985
Does Distraction With a Hand Held Video Game Reduce Preoperative and Emergence Anxiety in Children?
NCT00932685
Impact of Nebulized Dornase Alpha on Mechanically Ventilated Patients
NCT01095276
Prevalence and Treatment of Anemia in Rehabilitation Patients
NCT00511901
Combination Medications vs. Patch Alone for Medically-Ill Smokers
NCT00770666
Gemcitabine and Imatinib Mesylate as First-Line Therapy in Patients With Locally Adv. or Metastatic Pancreatic Cancer
NCT00161213
Quetiapine Treatment for Symptoms Associated With Borderline Personality Disorder
NCT00122070
Phase II Trial of Transdermal Estradiol for Hormone Refractory Prostate Cancer
NCT00176644
Trastuzumab, Docetaxel, and Carboplatin in Treating Women With Stage II, Stage III, or Inflammatory Breast Cancer
NCT00118053
Efalizumab for Eczema
NCT00146003
Etanercept With Tacrolimus for Psoriasis
NCT00134394
LAMPP Trial for Peripheral and Cutaneous T-Cell Lymphoma
NCT00161239
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 14 |
| Phase 2 | 22 |
| Phase 3 | 7 |
| Phase 4 | 7 |
Therapeutic Areas
How the University of Medicine and Dentistry of New Jersey early-phase archive is shaped
88 indexed studies, none listed as recruiting (0% open); 56 completed (64%).
Phase mix: 14 late (III/IV) vs 36 early (I/II) (early-phase heavy).
Top condition: Depression (2 trials), 9 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
University of Medicine and Dentistry of New Jersey: archived-pipeline peers nationwide
Peers matched on 88 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
University of Medicine and Dentistry of New Jersey sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 88 archived trials
- AbbVie (prior sponsor, Abbott) · 88 trials · 0% recruiting
- Pacira Pharmaceuticals · 88 trials · 6% recruiting
- Abbott Nutrition · 89 trials · 1% recruiting
- Florida International University · 89 trials · 20% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this University of Medicine and Dentistry of New Jersey page
88 registered trials is a research-attention snapshot, not an endorsement of University of Medicine and Dentistry of New Jersey or any single study.
- None of University of Medicine and Dentistry of New Jersey's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Depression is the condition University of Medicine and Dentistry of New Jersey studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Medicine and Dentistry of New Jersey pipeline card: 88 registered trials from official public datasets.Report a data error.